Lamprecht P - Search Results

1

Open-label, multicentre, dose-escalating phase II clinical trial on the safety and efficacy of tadekinig alfa (IL-18BP) in adult-onset Still's disease.

Gabay C, Fautrel B, Rech J, Spertini F, Feist E, Kötter I, Hachulla E, Morel J, Schaeverbeke T, Hamidou MA, Martin T, Hellmich B, Lamprecht P, Schulze-Koops H, Courvoisier DS, Sleight A, Schiffrin EJ. Gabay C, et al. Among authors: lamprecht p. Ann Rheum Dis. 2018 Jun;77(6):840-847. doi: 10.1136/annrheumdis-2017-212608. Epub 2018 Feb 22. Ann Rheum Dis. 2018. PMID: 29472362 Free PMC article. Clinical Trial.

2

[Rheumatology--searching for the individual therapeutic cocktail].

Hellmich B, Lamprecht P, Gross WL. Hellmich B, et al. Among authors: lamprecht p. Dtsch Med Wochenschr. 2005 Jun 24;130(25-26):1555-8. doi: 10.1055/s-2005-870863. Dtsch Med Wochenschr. 2005. PMID: 15965861 Review. German. No abstract available.

3

Leucoencephalopathy after treatment of Churg-Strauss syndrome with interferon {alpha}.

Metzler C, Lamprecht P, Hellmich B, Reuter M, Arlt AC, Gross WL. Metzler C, et al. Among authors: lamprecht p. Ann Rheum Dis. 2005 Aug;64(8):1242-3. doi: 10.1136/ard.2004.032664. Ann Rheum Dis. 2005. PMID: 16014692 Free PMC article. No abstract available.

4

Lack of efficacy of rituximab in Wegener's granulomatosis with refractory granulomatous manifestations.

Aries PM, Hellmich B, Voswinkel J, Both M, Nölle B, Holl-Ulrich K, Lamprecht P, Gross WL. Aries PM, et al. Among authors: lamprecht p. Ann Rheum Dis. 2006 Jul;65(7):853-8. doi: 10.1136/ard.2005.044420. Epub 2005 Nov 3. Ann Rheum Dis. 2006. PMID: 16269425 Free PMC article.

5

Advances in the therapy of Wegener's granulomatosis.

Hellmich B, Lamprecht P, Gross WL. Hellmich B, et al. Among authors: lamprecht p. Curr Opin Rheumatol. 2006 Jan;18(1):25-32. doi: 10.1097/01.bor.0000200369.24793.f5. Curr Opin Rheumatol. 2006. PMID: 16344616 Review.

6

Wegener autoantigen induces maturation of dendritic cells and licenses them for Th1 priming via the protease-activated receptor-2 pathway.

Csernok E, Ai M, Gross WL, Wicklein D, Petersen A, Lindner B, Lamprecht P, Holle JU, Hellmich B. Csernok E, et al. Among authors: lamprecht p. Blood. 2006 Jun 1;107(11):4440-8. doi: 10.1182/blood-2005-05-1875. Epub 2006 Feb 14. Blood. 2006. PMID: 16478888 Free article.

7

[Rheumatology-part 2. Research news concerning pathogenesis, epidemiology, diagnosis, and therapy of connective tissue disease].

Ahmadi-Simab K, Hellmich B, Lamprecht P, Gross WL. Ahmadi-Simab K, et al. Among authors: lamprecht p. Med Klin (Munich). 2006 Feb 15;101(2):127-37. doi: 10.1007/s00063-006-1018-8. Med Klin (Munich). 2006. PMID: 16501910 Review. German.

8

[Rheumatology -- Part 3. Research news concerning epidemiology, diagnosis, and therapy of primary systemic vasculitides].

Lamprecht P, Ahmadi-Simab K, Gross WL, Hellmich B. Lamprecht P, et al. Med Klin (Munich). 2006 Mar 15;101(3):212-25. doi: 10.1007/s00063-006-1027-7. Med Klin (Munich). 2006. PMID: 16648979 Review. German.

9

Treatment of refractory giant cell arteritis with cyclophosphamide:a retrospective analysis of 35 patients from three centres.

Loock J, Henes J, Kötter I, Witte T, Lamprecht P, Schirmer M, Gross WL. Loock J, et al. Among authors: lamprecht p. Clin Exp Rheumatol. 2012 Jan-Feb;30(1 Suppl 70):S70-6. Epub 2012 May 14. Clin Exp Rheumatol. 2012. PMID: 22640650

10

[Vasculitides].

Hellmich B, Lamprecht P, Moosig F. Hellmich B, et al. Among authors: lamprecht p. Z Rheumatol. 2015 Dec;74(10):852-3. doi: 10.1007/s00393-015-0013-y. Z Rheumatol. 2015. PMID: 26597726 German. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

232 results

Search Page